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The management of patients with cancer has evolved over recent
years due to the development of the concept of ‘evidence-based
medicine’ and a change in the patient–physician relationship.
Evidence-based medicine assigns a greater importance to the
results from clinical research in the medical decision-making
process than was assigned in the past. The change in the patient–
physician relationship has arisen from a request from patients
for better information concerning their illness and its manage-
ment, and for a greater level of involvement in the treatment
decisions.
Information and decision-making are both aspects of a patient-
centred approach to cancer care (this can also be defined as patient
education) and are integral parts of the health-care process,
although there is some controversy about the compatibility of
these concepts (Bensing, 2000; Straus and McAlister, 2000; Stewart,
2001).
ROLE OF PATIENT INFORMATION
The results from many studies have highlighted that patients
with cancer and their families express an important need for
information. Patient’s satisfaction with their management is
closely related to the response to this need. The patients’
understanding of their illness can help them to accept their
condition and to live with their illness and participate in the care
process. The absence of information seems to play an important
role in the difficulties of psychological adaptation associated with
being informed about the diagnosis and with the treatment
(Leydon et al, 2000). Several reports have identified patient
information as a major quality indicator in the overall manage-
ment of patients, for example, the French Agency for Accreditation
and Evaluation in Health (ANAES) defines patient information and
education as a criteria of quality in its accreditation system. In
addition, in many countries the patients’ rights for information
and the physicians’ obligations are enforced by law.
Nonetheless, the patients’ need to be informed about the
diagnosis, the treatment and the prognosis is often under-
estimated by physicians (Ong et al, 1995; Vennin et al, 1995;
Butow et al, 1997; Degner et al, 1997).
Patients’ information needs (type and amount of detail) differ
between individuals and change over the various stages of the care
process (i.e. diagnosis, treatment, follow-up, rehabilitation, remis-
sion, recurrent and advanced disease) and the patients’ acceptation
of the illness (Demma et al, 1999; Leydon et al, 2000). In addition,
several studies have shown that the patients who want to be
informed about the disease and treatment do not always want to
participate in the treatment decision (Cassileth et al, 1980; Suther-
land et al, 1989; Blanchard et al, 1990; Moumjid-Ferdjaoui and
Carrere, 2000). Some patients want to know why a particular
treatment is chosen, but they do not want to participate in the choice.
The discrepancies between physicians and patients’ perception
of information needs, and the length of consultation, which is often
insufficient, are important barriers to providing patients with
appropriate information within the clinical setting. Many patients
actively search for information on their illness and its treatment to
satisfy their need for information. For example, in a study of 191
patients with cancer in Canada, 71% reported that they had
actively searched for information and 50% had used Internet.
However, the physician remained the main information source for
83% of these patients (Chen and Siu, 2001).
PATIENT INFORMATION MATERIALS
The increased demand of patients with cancer for information
should be met with more complete information on the benefits and
also the side effects of treatment than has been previously available
(Coulter, 1998). However, in oncology, the treatment schemas are
often complicated, and the specialised technical language used is
difficult to understand for an untrained person (Hadlow and Pitts,
1991). This increased demand for appropriate information has led
to an increased development of information materials.
Unfortunately, much of the information available is inconsistent
with the scientific literature and does not meet the needs of the
patients (Coulter et al, 1999). They often give an overoptimistic
view of the treatment benefits and side effects, and they fail to
mention the primary information sources on which the informa-
tion is based. An analysis of more than 100 patient information
booklets performed by the FNCLCC found similar results
(unpublished). In addition, there was no clear mention of the
involvement of patients in the preparation of the booklets.
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In response to the evolution of the information-seeking behaviour
of patients, the French National Federation of Cancer Centres
(Federation Nationale des Centres de Lutte Contre le Cancer;
FNCLCC) initiated the SOR SAVOIR PATIENT project in 1998.
This is a programme for the development of evidence-based
patient information and it falls within the framework of patient
education. Patient education involves a series of structured
activities, which are integrated into the health-care process, with
the aim of improving patients’ understanding of cancer treatment
and their management of their disease. Patient education also aims
to provide psychological support, facilitate physician–patient
relationships and favour patients’ involvement in treatment
decisions. One important element is the development of informa-
tion documents adapted to the needs and experiences of the
patients and their families.
Objectives
The objectives of the SOR SAVOIR PATIENT project are:
 to enable patients to understand the fundamental medical
knowledge about their illness and its management;
 to improve the participation of patients in the management of
their illness and in treatment decisions;
 to improve the patients’ recognition and management of the
consequences and side effects of their illness and its treatment;
 to facilitate the dialogue between the patient and the physician.
Methodology
The medical information on which the patient information
produced by this project is based on clinical practice guidelines
produced by the FNCLCC for health-care specialists (Fervers et al,
2001). These guidelines are produced in the setting of a national
collaboration between the FNCLCC and the 20 regional cancer
centres in France, and the active participation of specialists from
public and private sectors, the French Oncology Federation of
university hospitals and many learned societies who form a
multidisciplinary working group for each specific guideline.
The development of the SOR SAVOIR PATIENT guides involves
the following steps (Figure 1).
 The relevant specialist SOR guideline is used as the primary
information source, and it is ‘translated’ into simple language by
a multidisciplinary team, including methodologists, a linguist, a
health anthropologist and oncology experts. This translation
aims to reword the scientific information to satisfy specified
readability criteria and the assumed knowledge level of the
reader. The end product is a knowledge base which is used to
produce the final patient information.
 Once established, the knowledge base is adapted to the
expressed needs of the patients and their families. Patients
and their family members are actively involved throughout the
process to identify specific information needs and adjust the
presentation of the information to the patients’ perception,
experience and their level of understanding. This is facilitated
throughout the development process using three complemen-
tary techniques: questionnaires, focus groups and individual
interviews.
 A professional working group is established (oncologists, organ
specialists and other health professions concerned by the
subject). This group is consulted throughout the development
steps which produce the knowledge base and the SOR SAVOIR
booklets. This working group validates the scientific and
medical content of the information in the knowledge base and
the booklets.
The final SOR SAVOIR PATIENT booklets are composed of
sections (e.g. general information, diagnosis, treatment) which can
be read independently, depending on the patients’ specific
information needs. Summaries are provided at the end of each
section, and these contain key information, identified by the
participating patients. There is a glossary at the end of each guide,
explaining any medical and/or technical terms used in the guide.
When relevant, there are practical information sheets providing
information about how different examinations are performed. In
the Appendix we present the translation from French to English
SOR specialist guideline
• Focus groups
• Postal survey
• Individual
interviews
SOR SAVOIR
knowledge
base
SOR SAVOIR PATIENT booklet
Patient involvement
Multidisciplinary team
• Cancer specialist
Dissemination
Patient education at the
local and regional level
• http://www.fnclcc.fr
• Booklets
• Methodologist
• Psychologist
• Linguist
• Anthropologist
Figure 1 Outline of the methodology used in the SOR SAVOIR Patient project
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practical information sheets. In addition to the information given
in these examples, practical information regarding administrative
and organisational matters is also given. However, since this
information is specific to the French setting, we did not include it
in the translated extracts.
Dissemination and implementation of the SOR SAVOIR
PATIENT booklets
The SOR SAVOIR PATIENT booklets are published on paper
(Figure 2), and are available free-of-charge on the FNCLCC website
(http://www.fnclcc.fr). Shortly, the information will be available on
the site in a hyperlink version. In the paper versions, attention is
paid to the presentation of the information, in particular, the
colours, the font (type and size) and also the page layout. Patients
are also involved in this step.
Production up to 2002
Based on this methodology, five patient information guides
(nonmetastatic breast cancer (2000, updated in 2002), neuroblas-
toma (2000), ovarian cancer (2002) and family risk of breast cancer
and ovarian cancer (2002)) have been published up to the end of
2002.
The publication of seven other booklets is planned for 2003:
understanding nonmetastatic non-small cell lung cancer; under-
standing cancer of the prostate; understanding osteosarcoma;
understanding chemotherapy; understanding radiotherapy; under-
standing medical imaging (including positron emission tomogra-
phy scanning); finding your way around social services and
administration for patients with cancer and their families.
So far, over 100 patients have participated in the elaboration of
the various SOR SAVOIR PATIENT booklets. Over 33000 copies of
the initial breast cancer booklet have been distributed from its
publication up to November 2002. In 2001, this booklet was
awarded a prize from the French medical journal ‘La Revue
Prescrire’ in recognition of its quality. In response to the changes
in available evidence, the booklet has been updated and was
published in December 2002.
PATIENT INFORMATION IN THE SETTING OF THE
PHYSICIAN–PATIENT RELATIONSHIP
Written information will never replace verbal communication in
the physician–patient relationship since it cannot respond to
individual fundamental needs, such as being listened to, or meet
the patient’s demand for individualised information and psycho-
logical support. Physicians, therefore, will remain the main
information source for cancer patients (Chen and Siu, 2001).
The SOR SAVOIR PATIENT project aims to respond to the
request from the patients for better information about their illness
and its management, and to facilitate the communication of that
information. The use of SOR SAVOIR PATIENT booklets during
the physician–patient encounter is intended to facilitate and aid
the dialogue between the patients and their physicians. This
dialogue should enable the needs of the patient to be identified,
and a personalised approach taken. In this setting, the booklets
offer an advantage because the organisation of the information in
the booklets enables the transmission of specific information,
depending on the phase of the disease and the process of care
(diagnosis, treatment, follow-up).
It is essential that the transmission of the information meets the
needs of both the health-care professionals and the patients. Since
the SOR SAVOIR PATIENT booklets aim to meet these needs, they
will play a major role in informing patients and will lead to an
improvement in their management. However, the impact of these
booklets on patients’ outcomes and physician–patient relation-
ships will have to be assessed. More research is needed, in
particular to better understand the cultural context and to identify
how to overcome existing barriers.
Figure 2 The SOR SAVOIR Patient booklets produced up to 2002
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EXPERIENCES
The development of good-quality patient information is a major
challenge in any initiative to improve the quality of patient care
(Coulter, 1998). It is generally agreed by researchers in this field
that the development of good-quality information material must
combine both evidence-based information sources and the active
participation of patients with cancer throughout the process.
This active patient involvement should ensure that their
specific information needs are satisfied, that the choice of lang-
uage is appropriate, and that the patient’s perception of illness
and treatments is taken into consideration. However, because the
information needs of patients differs, it is difficult to guarantee
that the participating patients are representative. The best
methods for involving patients in the process also need to be
explored. The development of evidence-based patient information
has raised other important questions, for example, how should
the probabilities associated with the benefits and harms be
presented. The results from some published studies suggest that
numerical risk information should be presented, but since these
results are from an English-speaking setting, and are, therefore,
probably culturally specific, we need to assess if they can be
extrapolated to other cultural and linguistic contexts (Edwards
et al, 2003).
Thus, there are many areas that require further research,
although we do know that practice and experiences vary from one
country to another. In the project to set up an International
Network for Clinical Practice Guidelines in Oncology (Philip et al,
2003), it is planned to address these research issues. The
organisational, cultural and linguistic differences will be explored
in the project in collaboration with the partners from different
settings.
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Appendix A. SOR-SAVOIR PATIENT–Fact sheet:
breast ultrasonography
What is breast ultrasonography?
Breast ultrasonography is a technique in which high-frequency
sound (ultrasound) waves are used to produce pictures of the
inside of the breast. This examination is performed by a
radiologist. The pictures produced are very useful to see if the
nodules detected during clinical examination of the breasts or on a
mammogram are liquid or solid.
This examination is complementary to a *mammography.
Although breast ultrasonography does not replace mammography
(the reference technique for breast examination), it is often
sufficient on its own.
Ultrasound provides ‘real-time’ images, that is, images or
pictures that can be seen immediately. It is therefore possible to
compare what has been detected by hand (during the clinical
examination of the breasts) with what is visible on the screen. Also,
ultrasound can be used to guide a needle towards an abnormality
to obtain a sample for further testing. There is no radiation risk
from this examination and it is not painful.
Although mammography is considered to be the standard
examination, it is not as good as ultrasonography for detecting
abnormalities in the breasts of teenagers, young women and
SOR SAVOIR PATIENT project
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examination of choice for these groups of women.
What should be done before breast ultrasonography?
(If the ultrasound is not performed at the same time
as the mammography)
A breast ultrasound can be performed at any time during your
menstrual cycle. There is no need to fast or avoid specific foods.
You should tell the radiologist if you are taking any medication.
Before coming for the examination there is no particular
preparation needed. However, you should not use any cosmetic
products (cream, perfume, etc.) on your skin or wear any jewellery.
You will be more comfortable if you wear a loose or buttoned top
and skirt or trousers, rather than a dress, since you will be asked to
remove the top half of your clothes.
Bring your previous mammograms, other breast radiology
reports (ultrasound, MRI) and also any results from previous
examinations of your breasts (e.g. *sampling, surgery reports) that
you have. These will be useful for the radiologist who will be able
to see the abnormalities that prompted your physician to send you
for a breast ultrasound. If the radiologist detects an abnormality,
the information in these documents may explain it, so that further
examinations may be unnecessary.
It is important to inform the radiologist about any surgical
interventions that you have had on your breast. Even if the scars
are not visible, they can affect the ultrasound image. Also tell the
radiologist if you have a breast implant.
What happens during the breast ultrasound examination? On arrival
you should report to reception and you will be asked to wait a few
minutes in the waiting room. Although the staff will make every effort
to ensure that you are seen on time, unexpected delays can arise and
you may have to wait a while.
A *radiographer will take your complete file containing your
doctor’s referral letter and all the results of your previous breast
examinations and will show you to the examination room. He/she
will explain what will happen during the examination.
The radiologist will ask you some questions, read the
mammography report (if you have one) and the referral letter
from your doctor. The radiologist will then perform a *clinical
examination of your breasts and under your arms. For the
ultrasound examination, a thin coating of lubricating gel will be
spread over the area to be imaged to guarantee good contact
between your skin and the ultrasound probe. The gel is
hypoallergenic and allergies are rarely seen. The radiologist will
examine all parts of your breast(s) to find the abnormality that
cannot be explained by the mammography.
The ultrasound examination usually takes about 5–10min, but
it will take a bit longer if samples are taken during the
examination. The radiologist will print out pictures of what has
been seen during the examination.
Follow-up and results of a breast ultrasound examination
The radiologist will explain the results of the clinical and
ultrasound examinations. However, it is not always possible to
give a definite diagnosis immediately. The pictures obtained with
the ultrasound enable certain abnormalities in the breast to be
seen, but it is not always possible to know for certain if the
abnormality is cancerous (i.e. malignant) or noncancerous (i.e.
benign). This often requires additional examinations. A report of
the examination will be given or sent to you. A copy of this report
will also be sent to the doctor(s) of your choice. It is very
important that you keep this report somewhere safe as it will be
useful for your next breast examination.
Don’t hesitate to ask the members of the medical team questions
about anything that is worrying you
GLOSSARY
Clinical examination: An examination performed by a doctor who,
after having asked you questions about your
illness, will examine you with a stethoscope
and use his/her hands to feel any lumps.
Magnetic resonance
imaging (MRI):
A technique that uses radio waves (identical
to those used in mobile phones) to produce
pictures. The radio waves make the water
molecules in your body vibrate or resonate.
The term magnetic signifies that a magnet is
used in the process of creating the pictures.
Mammogram: An image of the internal breast structure
produced using *mammography.
Mammography: A technique that uses a small amount of
X-rays to produce images of the internal
breast structure. More information can be
obtained by reading the fact sheet: ‘What
is mammography?’.
Radiographer: A person who helps the radiologist during
radiological examinations, and who is a
qualified technician in medical imaging.
Sampling: The act of taking something from your
body to analyse it. Blood or liquid samples
are taken using a fine needle. Taking
a sample of cells is called a fine needle
aspiration for cytology. Taking a tissue
sample is called a biopsy. Usually, a
needle is used to take breast samples
through the skin, after having numbed
the area. The needle is guided using a
radiology apparatus (ultrasound, mammo-
graphy, or more rarely, MRI). Sometimes
sampling requires surgery.
Appendix B. SOR-SAVOIR PATIENT–Fact sheet:
Preoperative breast localisation
What is preoperative breast localisation?
*Mammography can be used to detect abnormalities in the breast
that are so small that they cannot always be felt during a clinical
examination. Some of these abnormalities are difficult, or even
impossible, to locate during surgery. In addition, breasts do not
have the same shape when they are compressed for the
*mammogram and when you are lying on your back for surgery.
Preoperative breast localisation is used to show the surgeon
where an abnormality, detected on a mammogram, is located so
that it can be found more easily during an operation. It can also
help to ensure that the smallest amount possible of healthy breast
tissue is removed with the abnormality.
The radiologist will look at the results of any previous
examinations in your notes before deciding what method to use.
Sometimes localisation involves simply marking the skin with ink
to show the position of the abnormality. Often, however, a marker
is placed next to the abnormality inside the breast. This marker is
made up of a thread (metal or nylon) with a hook-like device at the
end. This device is hooked onto the abnormality that is to be
removed. The whole ‘thread–hook’ marker is folded inside a
needle. The needle is inserted through the skin. When it comes
into contact with the abnormality, the marker is released. The
radiologist may give you an injection to numb the area around
where the needle is to be inserted, so that you will not feel any
pain. This is all performed under radiological control (*mammo-
graphy or *ultrasound), so that the abnormality can be located
precisely.
The marker is usually inserted the day you are admitted to the
hospital, if you arrive the day before your operation is planned.
SOR SAVOIR PATIENT project
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operation, the marker will be positioned just before the operation.
We can assure you that this technique will not worsen your
illness, and it will not increase the likelihood of the spread of any
cancer cells. Very rarely, the insertion of the marker can cause a
*haematoma or a bruise. Certain patients, who are prone to
fainting when they are emotional, may suffer from a general feeling
of being unwell. When you make your appointment, please
mention if you think that you are likely to react in this way. We
can prescribe a drug to prevent this.
How to prepare for the preoperative breast localisation
Before coming for the examination there is no particular preparation
needed. However, you should not use any cosmetic products (cream,
perfume, etc.) on your skin or wear any jewellery. You will be more
comfortable if you wear a loose or buttoned top and skirt or trousers,
rather than a dress, since you will be asked to remove the top half of
your clothes. You should also follow any advice that the surgeon may
give you during your consultation. There is no need to fast if you are
admitted to hospital the day before your operation. You can eat a
light snack. You should tell the radiologist about any drugs you are
taking when you make the appointment. If you are taking aspirin
or drugs to thin your blood, the radiologist will explain what you
should do to temporarily stop taking these treatments.
Bring your previous mammograms and any other breast radio-
logy reports (ultrasound, MRI) that you have and also any results
from any other previous examinations that you have undergone for
your breasts (e.g. *samples, surgery reports). These documents will
help the radiologist to choose the most suitable technique to use.
What happens during preoperative breast localisation?
After completing the admission formalities, a receptionist will tell
you how to get to the surgical ward. You will be shown to your bed
by a nurse. When it is time for your appointment you will be taken
to the radiology department waiting room with your complete file.
Although the staff will make every effort to ensure that you are
seen on time, unexpected delays can arise and you may have to
wait a while.
The *radiographer will take your complete file containing the
surgeon’s letter, and all the results of your previous breast
examinations. He/she will wash your breast and explain what will
happen during the examination. The complete procedure takes, on
average, 30min.
If the radiologist is going to use ultrasound, you will be asked to
remove the top half of your clothing and to lie on your back. The
radiologist will then perform an ultrasound examination to re-
identify the location of the abnormality and decide exactly where
to insert the needle. You may be asked to place your arm over your
head and the skin around your breast will be disinfected.
The radiologist will then give you an injection under your skin
to numb the area around where the needle will be inserted. You
will feel the numbness within a few seconds and this will last for
more than 45min. You will not feel any pain during the exami-
nation or afterwards once the effects of the injection have worn off.
The needle will be inserted towards the abnormality, guided by
the image on the screen of the ultrasound machine. When the
needle reaches the abnormality, the marker will be released and
the needle removed. The thread will be visible on the outside of the
breast. A plaster will be placed on your breast to protect the thread.
If the radiologist is going to use mammography, you will be
asked to remove the top half of your clothing and to sit down. Your
breast will be slightly compressed and the radiographer will take
two images of the area with the abnormality at different angles to
each other. These images will be used to calculate the exact
position of the abnormality in your breast using a computer.
Sometimes a wire mesh guide is placed on the breast to help the
radiologist to guide the needle by inserting it through a hole in the
mesh facing the abnormality.
The radiologist will give you an injection under your skin to
numb the area around where the needle will be inserted. You will
feel the numbness within a few seconds and this will last for more
than 45min. You will not feel any pain during the examination or
afterwards once the effects of the injection have worn off.
The radiologist will insert the needle towards the abnormality,
guided by the calculation performed by the computer. When the
needle reaches the abnormality, the marker will be released and the
needle removed. The thread will be visible on the outside of the
breast. A plaster will be placed on your breast to protect the thread.
Immediately after positioning the marker, two new mammo-
grams (at different angles to each other) will be taken to make sure
that the marker is well positioned. These mammograms will be
given to the surgeon with the radiological report.
Follow-up and results of preoperative breast localisation In the
hours following the insertion of the marker, please tell the nurse in
your ward if you notice any bleeding under the plaster, or pain in
your breast.
During the day after the insertion, rest calmly in your bed and
avoid walking around the ward. Also, avoid any unnecessary effort
with your arm on the side where the marker has been inserted.
Do not sleep on your stomach or on the side where the marker
has been inserted. This could displace the marker in your breast.
The area on the breast through which the marker is placed is
generally not the same as that used in the operation on your breast.
There will be no scar at the place that the needle was inserted.
Don’t hesitate to ask the members of the medical team questions
about anything that is worrying you
GLOSSARY
Magnetic resonance
imaging (MRI):
A medical imaging technique that uses radio
waves (identical to those used in mobile
phones), which makes the water molecules
in your body vibrate or resonate. The term
magnetic signifies that a magnet is used in
the process of creating the images.
Mammogram: An image of the internal breast structure
produced using mammography.
Mammography: A technique that uses a small amount of
X-rays to produce images of the internal
breast structure. More information can be
obtained by reading the fact sheet: ‘What is
mammography?’.
Radiographer: A person who helps the radiologist during
radiological examinations, and who is a
qualified technician in medical imagery.
Ultrasound: An imaging technique in which high-fre-
quency sound (ultrasound) waves are used
to produce pictures of the inside of the
breast. The ultrasound image is very useful
for distinguishing between liquid and solid
nodules detected during clinical breast
examination or on a mammograph. This
examination can provide additional infor-
mation, particularly if the mammogram is
difficult to interpret. Breast ultrasound will
never replace mammography, because they
cannot provide the information necessary to
analyse certain structures, except in parti-
cular situations (e.g., pregnant women and
teenagers). More information can be ob-
tained on the fact sheet: ‘What is a breast
ultrasound?’.
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